Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients With Dilated Cardiomyopathy  Kati H. Miettinen, MSc, Susann Eriksson,

Similar presentations


Presentation on theme: "Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients With Dilated Cardiomyopathy  Kati H. Miettinen, MSc, Susann Eriksson,"— Presentation transcript:

1 Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients With Dilated Cardiomyopathy  Kati H. Miettinen, MSc, Susann Eriksson, PhD, Jarkko Magga, MD, PhD, Petri Tuomainen, MD, PhD, Johanna Kuusisto, MD, PhD, Esko J. Vanninen, MD, PhD, Anu Turpeinen, MD, PhD, Kari R. Punnonen, MD, PhD, Kim Pettersson, PhD, Keijo J. Peuhkurinen, MD, PhD  Journal of Cardiac Failure  Volume 14, Issue 6, Pages (August 2008) DOI: /j.cardfail Copyright © 2008 Elsevier Inc. Terms and Conditions

2 Fig. 1 Percentage of cTnAb+ patients among cTnI± patients at baseline, and after 6-month, 1-year, and 2-year follow-ups. Journal of Cardiac Failure  , DOI: ( /j.cardfail ) Copyright © 2008 Elsevier Inc. Terms and Conditions

3 Fig. 2 Kaplan-Meier cumulative survival curves for cTnI± patients. Survival time is expressed as years from the initial hospital study period. P value is derived by log-rank test. cTnI− patients (solid line); cTnI+ patients (dashed line). Journal of Cardiac Failure  , DOI: ( /j.cardfail ) Copyright © 2008 Elsevier Inc. Terms and Conditions


Download ppt "Clinical Significance of Troponin I Efflux and Troponin Autoantibodies in Patients With Dilated Cardiomyopathy  Kati H. Miettinen, MSc, Susann Eriksson,"

Similar presentations


Ads by Google